Invesaro

Stocks EXPE Financial statements

Financial statements

Expedia Group, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Expedia Group, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue8,77410,06011,22312,0675,1998,59811,66712,83913,69114,733
Cost of revenue1,5971,7571,9652,1631,6491,5221,6571,5731,4431,456
Gross profit7,1778,3039,2589,9043,5507,07610,01011,26612,24813,277
Selling and marketing4,3675,2985,7216,0602,5273,4995,4286,1076,8467,349
General and administrative678676774807589705748771805765
Operating income462625714903-2,7191861,0851,0331,3191,871
Interest expense173182190173360351277245246299
Interest income2034715918960207235255
Other non-operating income-185-208-229-128-432-224-547-15223-280
Pre-tax income277417485775-3,151-385381,0181,5421,591
Income tax164587203-423-53195330318290
Net income to minority interests-21-6-87-1163-9-109-107
Net income282378406565-2,612123527971,2341,294
EBITDA9391,2391,6731,813-1,8261,0001,8771,8402,1572,758
EPS, basic1.872.492.713.84-19.00-1.802.245.509.3910.32
EPS, diluted1.822.422.653.77-19.00-1.802.175.318.959.81
Shares, basic (weighted)150152150147141150157145131125
Shares, diluted (weighted)155156153150141150162150138132
Dividend per share1.001.161.241.320.341.60

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents1,7972,8472,4433,3153,3634,1114,0964,2254,1835,413
Short-term investments72.346828526242004828300320
Receivables1,3431,8662,1512,5247011,2642,0782,7863,2134,166
Other current assets200269292521654827774708689699
Total current assets3,4505,5405,1977,7355,6348,1818,7919,2309,81512,199
Property, plant and equipment1,3951,5751,8772,1982,2572,1802,2102,3592,4132,447
Lease right-of-use assets0611574407363357305296
Goodwill7,9428,2298,1208,1277,3807,1717,1436,8496,8446,872
Intangible assets2,4472,3091,9921,8041,5151,3931,2091,023817819
Long-term investments202280
Total assets15,77818,51618,03321,41618,69021,54821,56121,64222,38824,452
Accrued liabilities1,0911,2658081,0509798247877527661,027
Deferred revenue283326364321172166163164164163
Short-term debt050007490735001,0431,692
Total current liabilities6,1277,8798,06010,7145,4069,45010,77811,78313,61116,657
Long-term debt3,1593,7493,7174,1898,2167,7156,2406,2535,2234,469
Lease liabilities0532513360312314265254
Other non-current liabilities313408506389462413451473471505
Total liabilities10,08512,38712,38215,88015,68617,99617,83318,85619,58921,905
Total debt3,1594,2493,7174,9388,2168,4506,2406,2536,2666,161
Paid-in capital8,7949,1639,54912,97813,56614,22914,79515,39816,04316,565
Retained earnings129331517879-1,781-1,761-1,409-6326021,696
Treasury stock-4,511-4,822-5,742-9,673-10,097-10,262-10,869-13,023-14,856-16,786
Other comprehensive income-280-149-220-217-178-149-234-209-232-191
Shareholders' equity4,1324,5234,1043,9671,5102,0572,2831,5341,5571,284
Total equity5,6936,1295,6515,5363,0043,5523,7282,7862,7992,547
Total liabilities and equity15,77818,51618,03321,41618,69021,54821,56121,64222,38824,452
Shares outstanding138150148132123117

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income261372398572-2,728153436881,2241,301
Depreciation and amortization477614959910893814792807838887
Stock-based compensation242149203241205418374413458398
Deferred income tax-14-103-308-91-488-14570627478
Change in receivables-276-456-282-3681,781-721-838-741-467-983
Cash from operations1,5491,8451,9752,767-3,8343,7483,4402,6903,0853,880
Capital expenditures-749-710-878-1,160-797-673-662-846-756-770
Acquisitions-1-169-53800
Purchases of investments-45-1,811-1,803-1,346-685-201-60-28-549-628
Sales and maturities of investments1,0962,1378521,161232054978747
Cash from investing-718-1,581-559-1,553-263-931-580-800-1,262-531
Debt issued99001,2313,9451,964000985
Debt repaid00-5000-750-1,706-2,14100-1,044
Stock issued12821314928430147698606712
Share buybacks-456-312-923-743-425-165-607-2,137-1,839-1,930
Dividends paid-150-176-186-195-4800-200
Cash from financing-691688-1,4891754,077-973-2,624-2,096-1,745-2,136
Exchange rate effect-35147-139361-177-19016-165189
Net change in cash1051,099-2121,392411,66746-190-871,402
Free cash flow8001,1351,0971,607-4,6313,0752,7781,8442,3293,110
Interest paid154163196157313342291231231213
Income taxes paid12417428230410874102281184218

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $264.17 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin90.4%Gross profit / revenue.
Operating margin16.0%Operating income / revenue.
EBITDA margin21.7%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin15.5%Pre-tax income / revenue.
Net margin13.0%Net income / revenue.
FCF margin28.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin33.2%Cash from operations / revenue.
Effective tax rate16.3%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)168.4%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)7.0%Net income / average total assets.
Stock-based pay / revenue2.6%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue4.8%Capital expenditures / revenue.
D&A / revenue5.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y7.6%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y8.1%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y23.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y8.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y9.9%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y30.2%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y41.8%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y19.9%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y27.9%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y13.7%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y4.9%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y54.3%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y9.6%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y65.3%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y25.8%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y4.1%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y33.5%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y3.8%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y36.3%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-17.5%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-17.5%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-3.2%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y9.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y4.3%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y5.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-4.3%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-6.6%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.4%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.80xCurrent assets / current liabilities.
Quick ratio0.63x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.35x(Cash + short-term investments) / current liabilities.
Debt / equity4.52xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets18.8%Total debt / total assets.
Liabilities / assets91.5%Total liabilities / total assets.
Net debt-$1.67BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA-0.49xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage7.06xOperating income / interest expense.
Working capital-$4.05BCurrent assets - current liabilities.
Goodwill and intangibles / assets27.2%(Goodwill + intangible assets) / total assets.
Tangible book value-$6.69BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.54xRevenue / average total assets.
Fixed asset turnover6.44xRevenue / average property, plant and equipment.
Receivables turnover2.72xRevenue / average receivables.
Days sales outstanding134 days365 x average receivables / revenue.
FCF conversion219.0%Free cash flow / net income, when net income is positive.
Capex / operating cash flow14.5%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$16.61Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$128.11Revenue / diluted weighted shares.
FCF per share$36.38Free cash flow / diluted weighted shares.
Operating cash flow per share$42.56Cash from operations / diluted weighted shares.
Book value per share$10.56Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$58.47Tangible book value / shares outstanding.
Cash per share$62.26(Cash + short-term investments) / shares outstanding.
Payout ratio10.5%Dividends paid / net income, when net income is positive.
Dividends / FCF4.8%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF43.0%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$30.25BShare price x shares outstanding.
Enterprise value$28.58BMarket cap + total debt - cash - short-term investments.
P/E14.9xMarket cap / net income. Only when net income is positive.
P/S1.93xMarket cap / revenue.
P/B25.0xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF6.78xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF5.80xMarket cap / cash from operations, when positive.
EV/Sales1.82xEnterprise value / revenue.
EV/EBIT11.4xEnterprise value / operating income, when both are positive.
EV/EBITDA8.39xEnterprise value / EBITDA, when both are positive.
EV/FCF6.41xEnterprise value / free cash flow, when both are positive.
FCF yield14.7%Free cash flow / market cap.
Earnings yield6.7%Net income / market cap (the inverse of P/E).
Dividend yield0.7%Dividends paid over the period / market cap.
Shareholder yield7.0%(Dividends paid + share buybacks) / market cap.
PEG0.23xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was Expedia Group, Inc.'s revenue in fiscal 2025?

Expedia Group, Inc. reported revenue of $14.73B for fiscal 2025, 7.6% higher than the year before.

Was Expedia Group, Inc. profitable in fiscal 2025?

Yes. Net income was $1.29B, a net margin of 8.8%.

How much free cash flow did Expedia Group, Inc. generate in fiscal 2025?

Cash from operations of $3.88B minus capital expenditures of $770.0M left free cash flow of $3.11B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Expedia Group, Inc.